Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity

NCT01265849 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

928

Enrollment

INDUSTRY

Sponsor class

Conditions

Squamous Cell Carcinoma of the Oral Cavity
Squamous Cell Carcinoma of the Soft Palate

Interventions

BIOLOGICAL: LI
DRUG: Cyclophosphamide
DRUG: Indomethacin
DIETARY_SUPPLEMENT: Zinc
PROCEDURE: Surgery
DRUG: Cisplatin
RADIATION: Radiotherapy

Sponsor

CEL-SCI Corporation

Collaborators

[object Object]
[object Object]